Treating Hypertension in Older Adults
暂无分享,去创建一个
[1] W. Aronow,et al. Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. , 2004, The American journal of cardiology.
[2] Keith C. Norris,et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.
[3] H. A. Cameron,et al. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. , 1984, British medical journal.
[4] W. Aronow,et al. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. , 2001, The American journal of cardiology.
[5] L. Rubenstein,et al. Postural Hypotension in the Elderly , 1984, Journal of the American Geriatrics Society.
[6] W. Aronow,et al. Secondary hypertension: current diagnosis and treatment. , 2008, International journal of cardiology.
[7] W. Aronow. Treatment of Atrial Fibrillation and Atrial Flutter: Part II , 2008, Cardiology in review.
[8] J. Wei,et al. Postprandial reduction in blood pressure in the elderly. , 1983, The New England journal of medicine.
[9] W. Hazzard,et al. Principles of Geriatric Medicine and Gerontology , 2003 .
[10] W. Aronow,et al. Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility. , 1988, The American journal of cardiology.
[11] W. Aronow,et al. Adequacy of control of hypertension in an academic nursing home. , 2007, Journal of the American Medical Directors Association.
[12] W. Aronow,et al. Cardiovascular Drug Therapy in the Elderly , 2007, Cardiology in review.
[13] A. Hofman,et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.
[14] T. Hanslik,et al. Metabolic Adverse Reactions to Diuretics , 1995, Drug safety.
[15] B. Palmer. Renal dysfunction complicating the treatment of hypertension. , 2002, The New England journal of medicine.
[16] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[17] Mehra,et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. , 1990, Circulation.
[18] H. Kennedy,et al. Beta-blocker therapy in the cardiac arrhythmia suppression trial , 1994 .
[19] P. Vokonas,et al. Epidemiology of Coronary Heart Disease in the Elderly , 2008 .
[20] R. Hajjar. Commentary on "Embracing complexity: A consideration of hypertension in the very old". , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[21] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[22] M. Rich,et al. Disability and Frailty in Older Patients with Cardiovascular Disease , 2008 .
[23] W. Cushman,et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. , 2000, Hypertension.
[24] Bernard J. Gersh,et al. Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention , 2007, Circulation.
[25] W. Aronow,et al. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysf , 2001, The American journal of cardiology.
[26] J. Scott,et al. Diuretic induced gout: a multifactorial condition. , 1992, Annals of the rheumatic diseases.
[27] J. Crowley,et al. Minoxidil-associated pericarditis and fatal cardiac tamponade. , 1985, The Western journal of medicine.
[28] R. D'Agostino,et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. , 1987, Circulation.
[29] W. Aronow,et al. Postprandial Hypotension in 499 Elderly Persons in a Long‐Term Health Care Facility , 1994, Journal of the American Geriatrics Society.
[30] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[31] W. Aronow,et al. Association of Postprandial Hypotension With Incidence of Falls, Syncope, Coronary Events, Stroke, and Total Mortality at 29‐Month Follow‐Up in 499 Older Nursing Home Residents , 1997, Journal of the American Geriatrics Society.
[32] W. Aronow,et al. Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. , 1994, The American journal of cardiology.
[33] W. Aronow,et al. Treatment of hypertension and prevention of ischemic stroke , 2004, Current cardiology reports.
[34] J. Goodwin. Embracing complexity: A consideration of hypertension in the very old. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[36] W. Aronow,et al. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus. , 2001, The American journal of cardiology.
[37] Eli Warnock,et al. The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.
[38] J. Cohn,et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. , 1997, Circulation.
[39] W. Aronow,et al. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[40] D. Vidt,et al. Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone , 2000 .
[41] D. Sica,et al. Diuretic Combinations in Refractory Oedema States , 1996 .
[42] W. Hall,et al. Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.
[43] C M O'Connor,et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.
[44] J. Potter,et al. Cardiovascular Disease in the Elderly Patient , 1994 .
[45] W. Aronow,et al. Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women. , 1996, The American journal of cardiology.
[46] J. Guralnik,et al. Long‐Term Survival and Use of Antihypertensive Medications in Older Persons , 1995, Journal of the American Geriatrics Society.
[47] Barry R. Davis,et al. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.
[48] N. Madias,et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. , 1983, The New England journal of medicine.
[49] W. Aronow,et al. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. , 1997, The American journal of cardiology.
[50] V. Hirth,et al. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[51] W. Aronow,et al. Prevalence of postural hypotension in elderly patients in a long-term health care facility. , 1988, The American journal of cardiology.
[52] Li-sheng Liu,et al. Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.
[53] W. Aronow,et al. Simultaneous Measurements of Blood Pressures in Right and Left Brachial Arteries , 2004, Cardiology in review.
[54] W. Aronow,et al. Drug Treatment of Hypertension in Older Persons in an Academic Hospital‐Based Geriatrics Practice , 1999, Journal of the American Geriatrics Society.
[55] W. Aronow. Etiology, Pathophysiology, and Treatment of Atrial Fibrillation: Part 1 , 2008, Cardiology in review.
[56] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[57] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[58] W. Aronow,et al. Angina in the Elderly , 2008 .
[59] W. Aronow,et al. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. , 2002, The American journal of cardiology.
[60] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[61] R. Toto,et al. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. , 1991, Annals of internal medicine.
[62] W. Aronow. The heart and thyroid disease. , 1995, Clinics in geriatric medicine.
[63] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[64] W. Aronow,et al. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. , 1999, The American journal of cardiology.
[65] B. Davis,et al. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. , 2001, Controlled clinical trials.
[66] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[67] W. Aronow,et al. Risk Factors for Symptomatic Peripheral Arterial Disease in Older Persons in an Academic Hospital‐Based Geriatrics Practice , 2000, Journal of the American Geriatrics Society.
[68] W. Aronow,et al. Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. , 1996, The American journal of cardiology.
[69] R Peto,et al. Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man , 1971, Circulation research.
[70] R. Soriano. Dizziness and Syncope , 2007 .
[71] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[72] W. Aronow,et al. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. , 1991, The American journal of cardiology.
[73] S. Nattel,et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. , 1991, Circulation.
[74] Alan C. Wilson,et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. , 2005, The American journal of cardiology.